Medical News / Directly from ASH 2022: Claudia Morris, MD, Uncovers Potential New Mechanism of Action for Hydroxyurea

Data presented at the American Society of Hematology (ASH) Annual Meeting and Exposition showed the benefits of using Arganine (Arg) to supplement treatment of vaso-occlusive episdes (VOEs) in patients with sickle cell disease (SCD). While statistically insignificant, they observed a clinically relevant decrease in total parenteral opioid (TPO) and a shortened time to crisis resolution in both intervention groups treated with Arg compared with placebo. Source: MDMag To view the third party content, kindly click on the link below or read more. You will then leave this site and enter a third party site.

read more

In data presented as a late-breaking abstract during Digestive Disease Week (DDW) 2023 in Chicago, a ... read more
Direct endoscopic necrosectomy at index session, as opposed to the step-up approach, for patients with infected ... read more
Gut dysbiosis is often linked to persistent multi-system symptoms after SARS-CoV-2 infections or post-acute COVID-19 syndrome. In ... read more
The explosion of artificial intelligence has permeated through basically all walks of life, including medicine. In an ... read more